Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 6,649 | 5,629 | 5,926 | 3,672 | 3,691 |
| Cost of Goods | 1,975 | 2,066 | 2,403 | 1,151 | 1,154 |
| Gross Profit | 4,674 | 3,563 | 3,523 | 2,521 | 2,537 |
| Operating Expenses | 10,071 | 9,359 | 9,077 | 5,468 | 5,624 |
| Operating Income | -4,422 | -5,730 | -5,151 | -2,796 | -2,933 |
| Interest Expense | 0 | 0 | -479 | 30 | 38 |
| Other Income | 203 | 128 | -48 | -20 | 46 |
| Pre-tax Income | -4,219 | -5,602 | -4,720 | -2,846 | -2,925 |
| Income Tax | 76 | 6 | -1,393 | -2,408 | 13 |
| Net Income Continuous | -4,295 | -5,608 | -3,327 | -438 | -2,938 |
| Net Income Discontinuous | N/A | N/A | -631 | 69,612 | 2,666 |
| Net Income | $-4,295 | $-5,608 | $-3,958 | $69,174 | $-272 |
| EPS Basic Total Ops | -0.13 | -0.17 | -0.12 | 2.08 | -0.01 |
| EPS Basic Continuous Ops | -0.13 | -0.17 | -0.10 | -0.01 | -0.09 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.02 | 2.09 | 0.08 |
| EPS Diluted Total Ops | -0.13 | -0.17 | -0.12 | 1.98 | -0.01 |
| EPS Diluted Continuous Ops | -0.13 | -0.17 | -0.10 | -0.01 | -0.09 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.02 | 1.99 | 0.08 |
| EBITDA(a) | $-4,300 | $-5,536 | $-4,911 | $-2,738 | $-2,761 |